BioCurex, Inc.(fka BOCX)

[TheRaveninexile]

Has this been posted already?



SMALL CAP NETWORK BLOG
4/10/2008
Telemig (TMB) Too Hot to Handle? Biotech in Focus: CEL-SCI (CVM) & BioCurex (BOCX)

We mentioned a while back that we knew they’re project was going to take time, so we were going to give them plenty of it. Since then, Abbott (ABT) has indefinitely backed out of their deal with BioCurex…something of a game-changer. BioCurex is still going to proceed with the development of RECAF, but considering Abbott was such a big deal when they teamed up, I can only wonder what kind of blow this is to the company. They’ve been fairly quiet on the topic, which I don’t interpret as a good sign.

On the other hand, they signed Inverness (IMA) as a licensee not too long ago, so maybe the Abbott news doesn’t matter.

The European Patent Office has given them a patent on RECAF, which gives the company much more negotiation power than a ‘pending’ patent would.

Bottom line…we’re still following BioCurex, for the long haul. We don’t/can’t worry about the day to day stuff, as our interest primarily lies in the strength of their RECAF technology. Licensees and patents won’t change that.

http://www.smallcapnetwork.com/scb/telemig-tmb-too-hot-to-handle-biotech-in-focus-cel-sci-cvm-biocurex-bocx/1752/